Bio-Rad Laboratories (BIO) Equity Average (2010 - 2026)
Bio-Rad Laboratories (BIO) reported Equity Average of $7.2 billion for Q1 2026, up 7.97% year-over-year from $6.6 billion in Q1 2025, and up 0.81% on a QoQ basis from $7.1 billion in Q4 2025.
Bio-Rad Laboratories (BIO) has 17 years of Equity Average data on file, last reported at $7.2 billion in Q1 2026.
- Quarterly Equity Average rose 7.97% year-over-year to $7.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 billion (up 7.97% YoY) and the FY2025 annual result came in at $7.0 billion, down 8.41% from the prior year.
- Equity Average grew to $7.2 billion in Q1 2026 per BIO's latest filing, from $7.1 billion in the prior quarter.
- Across five years, Equity Average topped out at $11.9 billion in Q1 2022 and bottomed at $6.6 billion in Q1 2025.
- The 5-year median for Equity Average is $8.4 billion (2023), against an average of $8.3 billion.
- Peak annual rise in Equity Average reached 16.54% in 2022, while the deepest fall reached 37.65% in 2022.
- Tracing BIO's Equity Average over 5 years: stood at $9.0 billion in 2022, then retreated by 5.17% to $8.6 billion in 2023, then decreased by 18.07% to $7.0 billion in 2024, then rose by 0.95% to $7.1 billion in 2025, then climbed by 0.81% to $7.2 billion in 2026.
- Per Business Quant, the three latest BIO Equity Average figures stand at $7.2 billion (Q1 2026), $7.1 billion (Q4 2025), and $6.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | 7.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15 Bn |
| Dec 31, 2025 | 7.10 Bn |
| Sep 30, 2025 | 6.93 Bn |
| Jun 30, 2025 | 6.90 Bn |
| Mar 31, 2025 | 6.62 Bn |
| Dec 31, 2024 | 7.03 Bn |
| Sep 30, 2024 | 7.13 Bn |
| Jun 30, 2024 | 7.92 Bn |
| Mar 31, 2024 | 8.90 Bn |
| Dec 31, 2023 | 8.58 Bn |
| Sep 30, 2023 | 8.43 Bn |
| Jun 30, 2023 | 9.11 Bn |
| Mar 31, 2023 | 9.69 Bn |
| Dec 31, 2022 | 9.05 Bn |
| Sep 30, 2022 | 8.71 Bn |
| Jun 30, 2022 | 9.57 Bn |
| Mar 31, 2022 | 11.94 Bn |
| Dec 31, 2021 | 14.51 Bn |
| Sep 30, 2021 | 13.46 Bn |
| Jun 30, 2021 | 11.10 Bn |
| Mar 31, 2021 | 10.25 Bn |
| Dec 31, 2020 | 9.36 Bn |
| Sep 30, 2020 | 8.09 Bn |
| Jun 30, 2020 | 6.82 Bn |
| Mar 31, 2020 | 6.02 Bn |
| Dec 31, 2019 | 5.44 Bn |
| Sep 30, 2019 | 5.31 Bn |
| Jun 30, 2019 | 5.18 Bn |
| Mar 31, 2019 | 4.44 Bn |
| Dec 31, 2018 | 4.46 Bn |
| Sep 30, 2018 | 4.77 Bn |
| Jun 30, 2018 | 4.56 Bn |
| Mar 31, 2018 | 3.71 Bn |
| Dec 31, 2017 | 2.89 Bn |
| Sep 30, 2017 | 2.83 Bn |
| Jun 30, 2017 | 2.76 Bn |
| Mar 31, 2017 | 2.64 Bn |
| Dec 31, 2016 | 2.64 Bn |
| Sep 30, 2016 | 2.66 Bn |
| Jun 30, 2016 | 2.58 Bn |
| Mar 31, 2016 | 2.51 Bn |
| Dec 31, 2015 | 2.46 Bn |
| Sep 30, 2015 | 2.39 Bn |
| Jun 30, 2015 | 2.28 Bn |
| Mar 31, 2015 | 2.19 Bn |
| Dec 31, 2014 | 2.18 Bn |
| Sep 30, 2014 | 2.21 Bn |
| Jun 30, 2014 | 2.24 Bn |
| Mar 31, 2014 | 2.21 Bn |
| Dec 31, 2013 | 2.16 Bn |
| Sep 30, 2013 | 2.10 Bn |
| Jun 30, 2013 | 2.05 Bn |
| Mar 31, 2013 | 1.12 Bn |
| Dec 31, 2012 | 1.07 Bn |
| Sep 30, 2012 | 1.89 Bn |
| Jun 30, 2012 | 1.85 Bn |
| Mar 31, 2012 | 919.83 Mn |
| Dec 31, 2011 | 846.58 Mn |
| Sep 30, 2011 | 1.71 Bn |
| Jun 30, 2011 | 1.67 Bn |
| Mar 31, 2011 | 1.58 Bn |
| Dec 31, 2010 | 1.48 Bn |
| Sep 30, 2010 | 1.37 Bn |